| 1 | 08:00-08:05 |
Opening Remarks |
|
|||||
| 2 | 08:05-08:10 |
Opening Remarks |
|
|||||
| 3 | 08:10-08:15 |
Opening Remarks |
|
|||||
| 1 | 08:15-08:27 |
FANS Mini PCNL |
|
||||||||||||||
| 2 | 08:27-08:39 |
Hot Topics in the Diagnosis and Treatment of Complex Upper Urinary Tract Stones: Progress and Preliminary Exploration |
|
||||||||||||||
| 3 | 08:39-08:51 |
Chinese Expert Consensus on the Prevention and Management of Ureteral Stricture After Ureteroscopic Lithotripsy |
|
||||||||||||||
| 4 | 08:51-09:03 |
Mechanistic Validation of the Renal Tubular Injury Disease-Cluster Theory in Calcium Oxalate Nephrolithiasis: Dysregulated Phenylalanine Metabolism Injures Renal Tubules and Promotes Stone Formation |
|
||||||||||||||
| 5 | 09:03-09:15 |
Hot Topics in Minimally Invasive Treatment of Urolithiasis |
|
||||||||||||||
| 6 | 09:15-09:30 |
Discussion |
|
||||||||||||||
| 1 | 09:30-09:40 |
From Fluoroscopy to Ultrasound-Guided PCNL: Howto Make It Possible |
|
||||||||||||||
| 2 | 09:40-09:50 |
What is the Future for PCNL in the ERA of FANS |
|
||||||||||||||
| 3 | 09:50-10:00 |
Management of Lower Pole Stones |
|
||||||||||||||
| 4 | 10:00-10:10 |
Asymptomatic Non Obstructing Calyceal Stone: Treat or not to treat ! |
|
||||||||||||||
| 5 | 10:10-10:20 |
New Challenges PCNL: Technology Leads the Way |
|
||||||||||||||
| 6 | 10:20-10:30 |
Laser Applications in Endourology: Settings for Efficient Lithotripsy and BPH |
|
||||||||||||||
| 7 | 10:30-10:40 |
Discussion |
|
||||||||||||||
| 1 | 10:40-10:50 |
Development of a Novel Polymer-Based Material for Targeted Intervention in Sepsis |
|
||||||||||||||
| 2 | 10:50-11:00 |
Role and Mechanism of SIRT5-Mediated Desuccinylation of ACAA2 in Regulating Fatty Acid Oxidation in Renal Tubular Epithelial Cells During Calcium Oxalate Nephrolithiasis |
|
||||||||||||||
| 3 | 11:00-11:10 |
Development and Clinical Application of Super Multi-tract Minimally Invasive Percutaneous Nephrolithotomy (SMP-MPCNL) |
|
||||||||||||||
| 4 | 11:10-11:20 |
Quality Control of Etiological Diagnostic Techniques for Urolithiasis |
|
||||||||||||||
| 5 | 11:20-11:30 |
Application of Vascular Visualization Technology in PCN |
|
||||||||||||||
| 6 | 11:30-11:40 |
Molecular Characterization of a Multicenter Chinese Cohort of Cystine Stone Disease |
|
||||||||||||||
| 7 | 11:40-11:50 |
Preliminary Exploration of Real-World Studies on the Occurrence and Intervention of Urolithiasis |
|
||||||||||||||
| 8 | 11:50-12:00 |
Discussion |
|
||||||||||||||
| 1 | 13:30-13:40 |
Opening Remarks |
|
|||||
| 1 | 13:40-13:48 |
Multiscopic Combined Approaches for Complex Renal Stones in the New Era: Experience Sharing |
|
||||||||||||||
| 2 | 13:48-13:56 |
Development and Clinical Application of a Flexible Ureteroscopy Robot |
|
||||||||||||||
| 3 | 13:56-14:04 |
Use of Various Tubes and Access Channels in Percutaneous Nephrolithotomy |
|
||||||||||||||
| 4 | 14:04-14:12 |
Multicenter Clinical Study Results of the Vortex-Assisted Lithotripsy and Stone-Clearance System |
|
||||||||||||||
| 5 | 14:12-14:20 |
Preliminary Study of a Vortex-Assisted Intelligent Lithotripsy and Stone-Clearance System Versus Intelligent Pressure-Controlled FANS Flexible Ureteroscopy for Complex Renal Stones |
|
||||||||||||||
| 6 | 14:20-14:28 |
Mechanistic Study of Bacteroides fragilis-BSH in Inhibiting Calcium Oxalate Stone Formation via Regulation of Gut Bile Acid Metabolism |
|
||||||||||||||
| 7 | 14:28-14:36 |
Discussion |
|
||||||||||||||
| 1 | 14:36-14:44 |
Application of Nanozymes in the Prevention and Treatment of Renal Calcium Oxalate Stones |
|
||||||||||||||
| 2 | 14:44-14:52 |
Hydroxyapatite-induced IL6+ fibroblasts recruit GPNMB+ Macrophages to exacerbate Randall’s plaques |
|
||||||||||||||
| 3 | 14:52-15:00 |
Magnetic Field-Programmed FeCo Nanochains Drive Magnetomechanical-Thermal Synergistic Weakening and Minimally Invasive Lithotripsy of Calcium Oxalate Renal Pelvic Stones |
|
||||||||||||||
| 4 | 15:00-15:08 |
Multi-Omics Analysis Reveals That Isolithocholic Acid Promotes Calcium Oxalate Stone Formation via PARP1-Mediated Parthanatos |
|
||||||||||||||
| 5 | 15:08-15:16 |
Association Between Artificial Sweetener Intake and Kidney Stone Risk and an Aspartame-Based Mechanistic Investigation: A Study Integrating a Prospective Cohort and a Calcium Oxalate Nephrolithiasis Animal Model |
|
||||||||||||||
| 6 | 15:16-15:24 |
Current Status and Future of Robot-Assisted Flexible Ureteroscopic Lithotripsy |
|
||||||||||||||
| 7 | 15:24-15:32 |
Discussion |
|
||||||||||||||
| 1 | 15:32-15:40 |
Etiology and Pathogenesis of Infection-Related Staghorn (Struvite) Stones and Principles of PCNL Management and Follow-up |
|
||||||||||||||
| 2 | 15:40-15:48 |
Clinical Efficacy of Flexible Negative-Pressure Suction Sheath-Assisted Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy for 2–4 cm Upper Urinary Tract Stones |
|
||||||||||||||
| 3 | 15:48-15:56 |
Vortex-Assisted Novel Flexible Ureteroscopy Combined with Holmium Laser for Renal Stones Under Local Anesthesia in the Split-Leg Supine Position: A 31-Case Series |
|
||||||||||||||
| 4 | 15:56-16:04 |
Brief Apnea to Control Renal Motion During Flexible Ureteroscopic Laser Lithotripsy: A Prospective Randomized Controlled Trial |
|
||||||||||||||
| 5 | 16:04-16:12 |
A Novel BTCH-PSCS Imaging Grading System for Medullary Sponge Kidney Stones: Evaluation of Disease Characteristics and Benefits of Surgical Treatment |
|
||||||||||||||
| 6 | 16:12-16:20 |
Calyceal Forniceal Puncture vs Transmedullary Puncture: How Should We Choose? |
|
||||||||||||||
| 7 | 16:20-16:28 |
Discussion |
|
||||||||||||||
| 1 | 16:28-16:36 |
Comparative Efficacy of Retroperitoneoscopic Ureterolithotomy and Flexible Ureteroscopic Holmium Laser Lithotripsy for Complex Upper Ureteral Stones |
|
||||||||||||||
| 2 | 16:36-16:44 |
Efficiency and Safety of FANS Technology Based on a Dual-Laser Energy Platform: From In Vitro Experiments to Clinical Practice |
|
||||||||||||||
| 3 | 16:44-16:52 |
Lactoferrin Promotes Ectopic Calcification of Renal Interstitial Fibroblasts via the IGF-1/IGFBP2 Signaling Pathway |
|
||||||||||||||
| 4 | 16:52-17:00 |
The AR/miR-185-5p/TGF-β Axis in Renal Tubular Epithelial Cells Mediates Hyperuricemia-Induced Kidney Stone Formation by Impairing Macrophage Recruitment and M2 Polarization |
|
||||||||||||||
| 5 | 17:00-17:08 |
Selenium Attenuates Oxalate-Induced Renal Injury and Ferroptosis by Regulating YAP1 Ubiquitination and Degradation |
|
||||||||||||||
| 6 | 17:08-17:16 |
Discussion |
|
||||||||||||||
| 1 | 17:16-17:24 |
Auricular Acupuncture Combined with NSAIDs for Rapid Relief of Renal Colic Caused by Urolithiasis: A Single-Center Prospective Randomized Controlled Trial |
|
||||||||||||||
| 2 | 17:24-17:32 |
An End-to-End Risk Stratification Tool for the Prevention and Management of Ureteral Stricture After Ureteroscopic Lithotripsy |
|
||||||||||||||
| 3 | 17:32-17:40 |
Clinical Value of a Self-Developed Angled-Outlet Flexible Ureteroscope (“Flying Fox Scope”) for Lower-Pole Stones in Horseshoe Kidneys |
|
||||||||||||||
| 4 | 17:40-17:48 |
Preoperative Double-J Stenting Combined with FANS Reduces Ureteral Access Sheath-Related Injury and Postoperative Double-J Stent Duration: A Single-Center Prospective Randomized Controlled Trial |
|
||||||||||||||
| 5 | 17:48-17:56 |
Experimental Study of an ROS-Responsive Ureteral Stent Coating Delivery System Based on Target Screening in Clinical Samples for the Prevention of Ureteral Stricture |
|
||||||||||||||
| 6 | 17:56-18:04 |
Comparative Study of Intelligent Pressure-Controlled Retrograde Intrarenal Surgery and Mini-Percutaneous Nephrolithotomy for 2–3 cm Renal Stones |
|
||||||||||||||
| 7 | 18:04-18:12 |
Discussion |
|
||||||||||||||